Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (4)
  • 2024 (2)
  • 2023 (6)
  • 2022 (7)
  • 2021 (2)

Subject

  • Drug Trafficking (183)
  • Synthetic drugs (136)
  • Arrests/Convictions - Major (78)
  • Guns/Weapons (67)
  • Guilty Plea (60)
  • Seizures (Drugs/Property) (50)
  • Gangs (32)
  • Prescription Drugs (32)
  • HIDTA (28)
  • Major Law Enforcement Operation (28)
  • Task Forces/Task Force Officers (28)
  • OCDETF/Task Force (26)
  • Fake Pills (25)
  • Pharmaceuticals/Pharmacists/Physicians (21)
  • Money Laundering (17)
  • Take Back Day (16)
  • Overdose (14)
  • Fentanyl Free America (13)
  • Fentanyl Awareness (9)
  • Extraditions (8)
  • Outreach/Drug Prevention (6)
  • Press Conferences (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (5)
  • Campaigns (4)
  • Dark Web- Internet Trafficking (4)
  • International/Foreign Operations (4)
  • Public and Media Affairs - also see Congressional Affairs (4)
  • Counterfeit Pills (3)
  • One Pill Can Kill (3)
  • Cartel (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Congressional Affairs (1)
  • Critical Incident (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Diversion Division (26)

Drug Name

  • Oxycodone (4)
  • Opioids (1)

Field Division

  • Atlanta (13)
  • Chicago (18)
  • Dallas (6)
  • Detroit (1)
  • El Paso (11)
  • Houston (17)
  • Los Angeles (4)
  • Louisville (3)
  • Miami (10)
  • New England (36)
  • New Jersey (16)
  • New Orleans (8)
  • New York (27)
  • Omaha (4)
  • Phoenix (4)
  • Rocky Mountain (7)
  • San Diego (3)
  • San Francisco (10)
  • Seattle (25)
  • Sede (11)
  • St. Louis (11)
  • Washington, DC (34)
Clear All Results
26 Results - Showing 1 to 10
PRESS RELEASE

DEA and United Against Fentanyl Announce National Partnership for Walk for Lives 2026

NEWARK, N.J. –The U.S. Drug Enforcement Administration and United Against Fentanyl (UAF) announced a national partnership in support of DEA’s Fentanyl Free America initiative. Walk for Lives 2026 is a coordinated series of more than 100 family-led community events across the United States on July 11, 2026. These events aim...
PRESS RELEASE

Stericycle Resolves Criminal and Civil Investigations with over $56 Million Agreement for Long Running Failures in Handling Controlled Substances Bound for Disposal

SACRAMENTO, Calif. — Stericycle Inc., an international waste management company headquartered in Lake Forest, Illinois, has agreed to pay more than $56 million to resolve parallel criminal and civil investigations into its improper handling of controlled substances between 2015 and 2020, U.S. Attorney Eric Grant and Drug Enforcement Administration Special...
PRESS RELEASE

Camden County Pharmacist Charged with Illegally Dispensing Oxycodone

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration's New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a Camden County pharmacist was charged in an indictment with unlawfully distributing oxycodone, and his wife was separately charged...
PRESS RELEASE

DEA Hosts the 30th National Prescription Drug Take Back Day on Saturday, April 25th

SAN FRANCISCO – The U.S. Drug Enforcement Administration will host the 30th National Prescription Drug Take Back Day on Saturday, April 25, 2026, from 10 a.m. to 2 p.m. at nearly 4,200 locations nationwide- including over 67 drop off locations throughout the San Francisco region. Twice a year, DEA joins...
PRESS RELEASE

Sutter Facilities Agree to Pay $3.2 Million to Resolve Alleged Controlled Substances Act Violations

SACRAMENTO, Calif. — Sutter Medical Center, Sacramento, and Sutter Fairfield Surgery Center have agreed to pay $3.2 million to resolve allegations that they failed to effectively guard against theft and diversion of controlled substances, U.S. Attorney Eric Grant and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced...
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster